The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
申请公布号
WO2006138660(A2)
申请公布日期
2006.12.28
申请号
WO2006US23645
申请日期
2006.06.15
申请人
APOGEE BIOTECHNOLOGY CORPORATION;SMITH, CHARLES, D.;FRENCH, KEVIN, J.;ZHUANG, YAN
